Fully invested in Expertise
Our Team
Launch Therapeutics is backed by leading investors, Carlyle and its life sciences franchise, Abingworth.
Launch Tx was formed in 2022 with the vision of assembling an exceptional team that could redefine late-stage development. The goal? Expediting the pathway for therapies to be approved, and ultimately, delivered to the patients who need them. Meet the team of passionate professionals who are deeply committed to both the science – and the art – of delivering on that promise.
Executive Leadership
Board of Directors
Jonathan DeBenedetto
President / COO
Shao Chang, MD, PHD
SVP, Chief Medical Officer
Chhaya Shah
Chief Development Officer
Diane Wong
Chief Quality & Compliance Officer
James Cornwall
Head of Business Development
Haley Hopkins
Head of Human Resources
Bali Muralidhar
Global Head of Life Sciences & CIO
Kurt von Emster, CFA
Managing Partner
Travis Wilson
Managing Director, Carlyle
Sam Tang
Principal, Carlyle
Robert DeBenedetto
Managing Director, Abingworth
Together, We Deliver Excellence
Founded in 2022, Launch Tx has already made its mark — powering remarkable success across partnered programs.
6
Phase III Studies
955+
Sites
85+
Countries
4,200+
Patients